Stockscreener 앱 받기
19.95
1.84%
0.36
시간 외 거래:
20.00
0.05
+0.25%
Avalo Therapeutics Inc 주식(AVTX)의 최신 뉴스
Wall Street Zen Upgrades Avalo Therapeutics (NASDAQ:AVTX) to Hold - marketbeat.com
Why Did AVTX Stock Surge 45% In Pre-Market Today? - Stocktwits
Avalo Therapeutics CSO Jennifer Riley sells $52,012 in stock By Investing.com - Investing.com Nigeria
Avalo Therapeutics CSO Jennifer Riley sells $52,012 in stock - Investing.com
Avalo Therapeutics CMO Mittie Doyle sells $13,580 in stock - Investing.com
AVTX Surges Over 50% After Hours as Skin Disease Drug Shows Desired Clinical Results - Stocktwits
Avalo Therapeutics Stock Price Forecast. Should You Buy AVTX? - StockInvest.us
Caligan Partners (NASDAQ: AVTX) reports 5.9% Avalo Therapeutics ownership on amended 13G - Stock Titan
RA Capital discloses 3.48M-share Avalo Therapeutics (AVTX) position in latest filing - Stock Titan
Avoro Capital and Behzad Aghazadeh report 4.44% AVTX stake in 13G/A filing - Stock Titan
Sei Investments Co. Invests $849,000 in Avalo Therapeutics, Inc. $AVTX - marketbeat.com
Avalo Therapeutics (AVTX) sees 5.5% stake reported by Affinity Asset Advisors and Michael Cho - Stock Titan
Avalo Therapeutics (AVTX) Chief Strategy Officer Jennifer Riley Sells 2,655 Shares - GuruFocus
Avalo Therapeutics (AVTX) CMO Mittie Doyle exercises options and sells 679 shares - Stock Titan
Avalo Therapeutics (AVTX) CSO Riley sells 2,655 shares at about $19.59 - Stock Titan
Avalo Therapeutics, Inc. $AVTX Shares Bought by Renaissance Technologies LLC - marketbeat.com
Avalo Therapeutics (AVTX) insider plans NASDAQ resale of 2,655 ESPP shares - Stock Titan
Equities Analysts Issue Forecasts for AVTX Q3 Earnings - marketbeat.com
Do Avalo Therapeutics’ (AVTX) Widening Losses But Better EPS Reveal a Turning Point in Strategy? - Yahoo Finance
Avalo Therapeutics (AVTX) Short Interest & Short Float | Updated Aug 2026 - marketbeat.com
Avalo Therapeutics (AVTX) insider schedules 679-share stock sale after option exercise - Stock Titan
Avalo Therapeutics (AVTX) Holds Near $18.29 as Shares Consolidate in a Narrow Trading BandSentiment Extreme - dars.gov.et
Avalo Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Bank of America Securities Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX) - The Globe and Mail
Avalo Therapeutics (NASDAQ:AVTX) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $30 to $58 - Moomoo
AVTX Maintains Buy Rating by Guggenheim -- Price Target Lowered to $48 - GuruFocus
Avalo Therapeutics Inc (AVTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FMR LLC discloses 10.8% Avalo Therapeutics (AVTX) holding in Schedule 13G/A - Stock Titan
AVTX Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
HC Wainwright Has Lowered Expectations for Avalo Therapeutics (NASDAQ:AVTX) Stock Price - MarketBeat
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
AVTX SWOT Analysis: Financial Challenges and Promising Pipeline Revealed in 10-Q Filing - GuruFocus
Avalo Therapeutics (NASDAQ:AVTX) Issues Quarterly Earnings Results, Misses Expectations By $0.27 EPS - MarketBeat
Price-Driven Insight from (AVTX) for Rule-Based Strategy - Stock Traders Daily
Avalo Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Avalo Therapeutics, Inc. Stock 12‑Month Price Target Raised to $45.33, Implies 141% Upside - TradingView
Avalo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates - manilatimes.net
Avalo Therapeutics Announces Plans for Phase 3 Abdakibart HS Program, Advancement of AVTX-010 and Second Quarter 2026 Financial Results - Quiver Quantitative
Avalo Therapeutics, Inc. 2026: Revenue ($36.94M), Net income ($36.36M), EPS ($0.83) — 10-Q Summary - TradingView
Avalo Therapeutics reports Q2 2026 net loss $36.4M; cash and investments $472.2M - TradingView
Avalo Therapeutics posts corporate deck spotlighting IL-1β inhibitor pipeline for hidradenitis suppurativa - Bitget
Avalo Therapeutics Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
DV Trading LLC Invests $5.38 Million in Avalo Therapeutics, Inc. $AVTX - marketbeat.com
Avalo Therapeutics Inc Revenue Breakdown – DUS:C6K0 - TradingView
Avalo Therapeutics Inc (AVTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Avalo Therapeutics (AVTX) Expected to Post Earnings on Thursday - marketbeat.com
Avalo Therapeutics earnings up next: Pipeline progress in focus By Investing.com - Investing.com Canada
Avalo Therapeutics (NASDAQ:AVTX) Insider Mittie Doyle Sells 1,000 Shares - marketbeat.com
Avalo Therapeutics Inc (AVTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Exome Asset Management LLC Makes New $2.38 Million Investment in Avalo Therapeutics, Inc. $AVTX - marketbeat.com
Avalo Therapeutics Inc (AVTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BlackRock Inc. (AVTX) discloses 6.5% Avalo Therapeutics stake on Schedule 13G - Stock Titan
AVTX|Avalo Therapeutics Inc|Price:19.915|Chg%:+1.475 - TradingKey
Avalo Therapeutics Inc (AVTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avalo Therapeutics Inc (AVTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Orbimed Advisors LLC Has $7.09 Million Stock Position in Avalo Therapeutics, Inc. $AVTX - marketbeat.com
Avalo Therapeutics Inc Revenue Breakdown – TRADEGATE:C6K0 - TradingView
Avalo Therapeutics Inc (AVTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
Affinity Asset Advisors LLC Purchases 289,786 Shares of Avalo Therapeutics, Inc. $AVTX - marketbeat.com
Avalo Therapeutics(AVTX) Stock Options Chain | Quotes & News - Moomoo
AVTX|Avalo Therapeutics Inc|Price:18.440|Chg%:+0.680 - TradingKey
Avalo Therapeutics Inc (AVTX) Balance Sheet - TradingKey
Avalo Therapeutics Inc (AVTX) Cash Flow - TradingKey
AVTX|Avalo Therapeutics Inc|Price:18.210|Chg%:+0.450 - TradingKey
Cantor Fitzgerald reiterates Avalo Therapeutics stock rating By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Avalo Therapeutics stock rating - Investing.com
1.80%
1.77%
자본화:
|
볼륨(24시간):